Teva Pharmaceuticals Usa, Inc. Employment Transition Plan — Form 5500 plan (Teva Pharmaceuticals Usa, Inc.)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Teva Pharmaceuticals Usa, Inc. Employment Transition Plan is a benefit plan reported by Teva Pharmaceuticals Usa, Inc. under EIN 22-1734359 and plan number 511. The latest loaded filing year is 2023. The filing reports 5,222 participants and not reported in the loaded dataset in end-of-year plan assets, where available in the loaded dataset.
Form 5500 plan profile · 2023
Key reported metrics
Net assets (EOY)Not reported
Participants5.2KCovered participants reported5,222
Assets / participantNot reported
Provider compensationNone reported
- Plan sponsor
- Teva Pharmaceuticals Usa, Inc.
- EIN
- 22-1734359
- Plan number
- 511
- Plan type
- 2
- Location
- Parsippany, NJ
- Latest filing year
- 2023
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 5,222 | — | 20251215145310NAL0003676594001 |
Reported financial statement
This plan is loaded, but Schedule H / I financial-statement detail is not present for it in the current loaded dataset.
Service provider compensation (Schedule C)
No Schedule C service provider compensation is loaded for this plan yet.